Koers Stratec Biomedical AG Xetra
Aandelen
DE0007289001
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
||
- EUR | - |
29/04 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank is neutraal gestemd over het aandeel | ZD |
26/04 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg herhaalt het Neutraal advies | ZD |
Omzet 2024 * | 266 mln. 287 mln. | Omzet 2025 * | 290 mln. 313 mln. | Marktkapitalisatie | 520 mln. 561 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 16 mln. 17,26 mln. | Nettowinst (verlies) 2025 * | 23 mln. 24,81 mln. | EV/omzet 2024 * | 2,39 x |
Nettoschuld 2024 * | 116 mln. 125 mln. | Nettoschuld 2025 * | 79,62 mln. 85,9 mln. | EV/omzet 2025 * | 2,07 x |
K/w-verhouding 2024 * |
31,9
x | K/w-verhouding 2025 * |
22,4
x | Werknemers | - |
Dividendrendement 2024 * |
2,03% | Dividendrendement 2025 * |
2,12% | Vrij verhandelbaar | 59,43% |
Recentste transcriptie over Stratec Biomedical AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 56 | 01-03-98 |
Robert Siegle
DFI | Director of Finance/CFO | 57 | 01-05-98 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 58 | 29-05-19 |
Georg Heni
CHM | Chairman | 66 | 20-05-22 |
Rolf Vornhagen
BRD | Director/Board Member | 71 | 21-07-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,29% | 225 mld. | |
+8,76% | 186 mld. | |
+12,90% | 135 mld. | |
+25,95% | 107 mld. | |
+0,34% | 63,56 mld. | |
+11,08% | 51,04 mld. | |
+5,62% | 51,32 mld. | |
+6,28% | 43,3 mld. | |
+4,80% | 36,99 mld. |